ABOUT US
ABOUT US
R N Laboratories (RNL) is a premier disinfectant API manufacturer, established in 1994 and supplying to over 70 countries worldwide. With production facilities in the USA and India, and warehousing in the UK and sales offices in China and South Africa, RNL is well positioned to meet the needs of its clients effectively and efficiently.
Founded by the brother duo Rohit and Nitin Garg, RNL has grown to become one of the few Indian companies to have acquired and grown the international companies in developed markets such as the USA, Switzerland, UK, Europe, and Hong Kong. The company operates from its headquarters in New Jersey and is dedicated to expanding its presence globally.
RNL’s state-of-the-art manufacturing facility in Surat, India, produces API with wide application in the disinfectant industry, serving the pharma, healthcare, personal care, water treatment, and vaping industries. With a focus on security of supply, RNL has extended its reach with warehousing facilities in Europe, UK, Asia, North America, and Africa.
RNL is committed to quality and safety and operates according to the highest standards, earning accreditations from globally recognized organizations such as Ernst & Young, SAP, and Citibank. As a trusted and reliable source of high-quality API products, RNL has a proactive and collaborative approach to its commercial ventures.
In addition to its commercial success, RNL is committed to making a positive impact on the world and supports iconic philanthropic organizations such as UNICEF, WHO, and The Red Cross through its own trust, the “Neelam Garg Foundation”. The foundation supports girls’ education for underprivileged sections of society, reflecting RNL’s strong commitment to excellence and its passion for making a difference.
With a strong commitment to growth and excellence, RNL is poised to continue its position as a leading player in the global pharmaceutical industry.
OUR JOURNEY
-
1994
Started operations in 1994 with products Triclosan, Hexachloroethane
-
2000
Diversified into anti-bacterial and disinfectants: Chlorohexidine salts
-
2008
DMF filed for Chlorhexidine Gluconate 20% solution and Chlorhexidine salts
-
2012
R N LABORATORIES AFRICA LTD- South Africa
-
2013
R N EUROPE- UK - CEP from EDQM for CHG 20%
-
2016
R N LABORATORIES AG Switzerland
-
2017
GARONIT PHARMACEUTICAL-USA
-
2018
R N LABORATORIES HONG KONG BPR from ECHA for CHG 20%
-
2021
R N LABORATORIES UK LTD- England